Dental Care Clinics in Weirton, WV Accepting Medicare
6 Dental Care Clinics found. Showing 1 - 6
 Michael J Hedmond Dds Pllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 332 Penco Rd, Weirton, WV 26062 Phone: 304-723-1230 |
B.j. Palma, D.m.d., Inc. Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 3143 West St, Weirton, WV 26062 Phone: 304-748-5040 Fax: 304-748-5042 |
H. E. Henry, Dds Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 200 Saint Thomas Dr, Weirton, WV 26062 Phone: 304-723-7200 Fax: 304-723-4460 |
Wesley A. Pate, D.d.s. Pllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 382 Penco Rd, Weirton, WV 26062 Phone: 304-723-1514 |
Mitchell A Sagan Dds Inc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 420 Elaine Street, Weirton, WV 26062 Phone: 304-723-2021 Fax: 304-723-2030 |
Jeremy M. Crow Dds, Inc. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3245 West St, Weirton, WV 26062 Phone: 304-748-4210 Fax: 304-748-2210 |
News Archive
Annual dental expenditure of Ohio and Georgia residents is less than the national average
The annual amount spent by Georgians and Ohioans or their insurers for dental care in 2006 averaged about $150 less than the national average of $607, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Study estimates real-world prevalence of myopic choroidal neovascularization in the U.S.
A new study estimates that 9.6 million adults in the United States are highly myopic, or severely nearsighted. Of those, nearly 820,000 have a degenerative form of the disease and more than 41,000 suffer a complication called myopic choroidal neovascularization that could cause long-term vision loss, with women at higher risk.
Levels of insulin-related proteins indicate risk of death in some colorectal cancer patients
A pair of proteins may help explain why people with surgically removed colorectal cancer and who are overweight, physically inactive, and follow a Western-pattern diet may have an increased risk of dying of the disease or other causes, Dana-Farber Cancer Institute scientists report in a new study.
OBD presents results of immunotherapy studies at FNIH Biomarker Consortium Cancer Steering Committee's annual meeting
Oxford BioDynamics Plc, a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, presented its latest results at the annual meeting of the Foundation for National Institute for Health Biomarker Consortium Cancer Steering Committee, held in Washington, DC on 6-7 November 2017.
Japanese Patent granted for Pharmalink AB's Nefecon
Pharmalink AB announced today that it has been granted Japanese Patent No 4326696, "Methods and means for treating glomerulonephritis" for its product Nefecon(R) which is being developed to treat IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD). Counterparts of the patent have been issued for other territories including the EU, US and China.
› Verified 5 days ago